Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of €56.11 Million could theoretically repay 0% of its total liabilities (€3.22 Billion) in one year. See XIN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Company Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Also explore Shandong Xinhua Pharmaceutical Company L annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Company Limited. For market capitalisation and broader financial context, see XIN stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €533.73 Million | €3.73 Billion | ▲ +48.0% |
| 2024 | 0.10x | €367.61 Million | €3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | €265.28 Million | €3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | €758.24 Million | €3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | €259.12 Million | €3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | €420.19 Million | €3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | €348.27 Million | €3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | €323.91 Million | €3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | €389.97 Million | €2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | €439.35 Million | €2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | €348.64 Million | €2.51 Billion | ▼ -6.4% |
| 2014 | 0.15x | €346.34 Million | €2.33 Billion | ▲ +200.6% |
| 2013 | 0.05x | €104.99 Million | €2.13 Billion | — |